Volume 11, Issue 1 (2025)                   Pharm Biomed Res 2025, 11(1): 69-74 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farzaneh A H, Khosravi N. Ergotamine/Caffeine Overdose in a Female Suffering From Migraine Headache: A Case Report. Pharm Biomed Res 2025; 11 (1) :69-74
URL: http://pbr.mazums.ac.ir/article-1-618-en.html
1- Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
2- oxicology and Forensic Medicine Division, Mazandaran Registry Center for Opioids Poisoning, Mazandaran University of Medical Sciences, Sari, Iran. & Antimicrobial Resistance Research Center, Mazandaran University of Medical Sciences, Sari, Iran. & Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
Abstract:   (115 Views)
Background: Ergotamine is a very common antimigraine and is widely used in the management of headaches such as cluster and acute migraines. However, Ergotamine poisoning is an infrequent condition, and there are very few cases reported. Tachycardia and arterial spasms occasionally occur because of accidental overdosing or interactions. There are no specific antidotes, and none of the current treatments have proven efficacy. 
Case Report: Here, we describe a young female who intentionally consumed approximately 20 mg of ergotamine and experienced vomiting, vasospasm, and tachycardia. Fortunately, her symptoms improved with the administration of conservation therapy, enoxaparin, nifedipine, and methylprednisolone. 
Conclusion: Clinicians should be aware of the potential risk of vasoconstriction associated with ergotamine/caffeine toxicity and closely monitor patients for these side effects.
Full-Text [PDF 530 kb]   (63 Downloads) |   |   Full-Text (HTML)  (4 Views)  
Type of Study: case report | Subject: Toxicology

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb